These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2595312)

  • 21. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of stimulation and inhibition of acid secretion on gastric damage induced by platelet-activating factor.
    Piqué JM; Pérez Ayuso RM; Bilbao J; Terés J
    Dig Dis Sci; 1991 Dec; 36(12):1715-20. PubMed ID: 1748040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of platelet-activating factor on vascular permeability and granulocyte recruitment in the rat trachea.
    Brokaw JJ; Prow DM; Kirsch CM; White GW
    Lung; 1991; 169(2):109-19. PubMed ID: 1648156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of platelet-activating factor-induced gastric mucosal damage in rats.
    Yoshida N; Yoshikawa T; Ando T; Naito Y; Oyamada H; Takemura T; Tanigawa T; Sugino S; Kondo M
    Scand J Gastroenterol Suppl; 1989; 162():210-4. PubMed ID: 2556790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis.
    Albert DH; Malo PE; Tapang P; Shaughnessy TK; Morgan DW; Wegner CD; Curtin ML; Sheppard GS; Xu L; Davidsen SK; Summers JB; Carter GW
    J Pharmacol Exp Ther; 1998 Jan; 284(1):83-8. PubMed ID: 9435164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zinc acexamate reduces gastric damage induced by platelet-activating factor.
    Escolar G; Navarro C; Galmés JL; Casanovas LI; Bulbena O
    Prostaglandins Leukot Essent Fatty Acids; 1989 Oct; 38(1):49-53. PubMed ID: 2608701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of cysteinyl leukotrienes is of minor importance in platelet-activating factor-induced reduction of perfusion rate in the rat gastric vascular bed.
    Dembinska-Kiec A; Novak P; Peskar BM; Peskar BA
    Prog Clin Biol Res; 1989; 301():487-91. PubMed ID: 2798459
    [No Abstract]   [Full Text] [Related]  

  • 29. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants.
    Wallace JL; Whittle BJ
    Prostaglandins; 1986 May; 31(5):989-98. PubMed ID: 3726156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240.
    Sirois MG; Jancar S; Braquet P; Plante GE; Sirois P
    Prostaglandins; 1988 Nov; 36(5):631-44. PubMed ID: 3238010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock.
    Wallace JL; Hogaboam CM; McKnight GW
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G140-6. PubMed ID: 2372058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of neutrophils in gastric damage induced by platelet activating factor.
    Etienne A; Thonier F; Hecquet F; Braquet P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):422-5. PubMed ID: 3244384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
    Pedersen KE; Rigby PJ; Goldie RG
    Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CNS effects of platelet-activating factor on the rat stomach.
    Cucala M; Wallace JL; Salas A; Guarner F; Rodríguez R; Malagelada JR
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():67-71. PubMed ID: 2725123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin-1 induces neutrophil-independent vascular injury in the rat gastric microcirculation.
    Lopez-Belmonte J; Whittle BJ
    Eur J Pharmacol; 1995 May; 278(1):R7-9. PubMed ID: 7664809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs.
    Sakurai T; Yamaguchi S; Iwama T; Nagai H
    Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):95-9. PubMed ID: 7972272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of histamine in aggravation of gastric acid back-diffusion and vascular permeability in septic rats.
    Hung CR
    Chin J Physiol; 2001 Dec; 44(4):199-206. PubMed ID: 11908549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.
    Evans TW; Chung KF; Rogers DF; Barnes PJ
    J Appl Physiol (1985); 1987 Aug; 63(2):479-84. PubMed ID: 3115939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.
    Filep JG; Földes-Filep E
    Br J Pharmacol; 1993 Dec; 110(4):1347-52. PubMed ID: 8306074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.